PRANA BIOTECHNOLOGY LTD's ticker is PRAN and the CUSIP is 739727204. A total of 14 filers reported holding PRANA BIOTECHNOLOGY LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,000 | +66.7% | 2,512 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 2,512 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | 0.0% | 2,512 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 2,512 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | -37.5% | 2,512 | 0.0% | 0.00% | – |
Q4 2017 | $8,000 | +14.3% | 2,512 | 0.0% | 0.00% | – |
Q3 2017 | $7,000 | 0.0% | 2,512 | -14.2% | 0.00% | – |
Q2 2017 | $7,000 | -22.2% | 2,928 | +0.4% | 0.00% | – |
Q1 2017 | $9,000 | +350.0% | 2,916 | +218.3% | 0.00% | – |
Q4 2016 | $2,000 | -50.0% | 916 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | +33.3% | 916 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | – | 916 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADVANTAGE INVESTMENT MANAGEMENT, LLC | 1,115 | $2,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 2,070 | $4,000 | 0.00% |
NEXT Financial Group, Inc | 583 | $1,000 | 0.00% |
Advisor Group, Inc. | 2,512 | $5,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 41,155 | $79,000 | 0.00% |
American Portfolios Advisors | 83 | $156 | 0.00% |
MORGAN STANLEY | 218,810 | $411,000 | 0.00% |
NEXT Financial Holdings | 583 | $1,000 | 0.00% |